BR102020024403A2 - Antígenos peptídeos sintéticos para o diagnóstico do sars-cov-2 - Google Patents

Antígenos peptídeos sintéticos para o diagnóstico do sars-cov-2

Info

Publication number
BR102020024403A2
BR102020024403A2 BR102020024403A BR102020024403A BR102020024403A2 BR 102020024403 A2 BR102020024403 A2 BR 102020024403A2 BR 102020024403 A BR102020024403 A BR 102020024403A BR 102020024403 A BR102020024403 A BR 102020024403A BR 102020024403 A2 BR102020024403 A2 BR 102020024403A2
Authority
BR
Brazil
Prior art keywords
synthetic peptide
covid
kit
test
cov
Prior art date
Application number
BR102020024403A
Other languages
English (en)
Other versions
BR102020024403B1 (pt
BR102020024403A8 (pt
Inventor
Castello Branco Beirão Breno
Ricardo Soccol Carlos
Lucas Pires Ramos Eliezer
Do Nascimento Ferreira Gabriela
Michel Dela Vedova Costa Jean
Cesar De Carvalho Júlio
Hospinal Santiani Manuel
Max Ingberman
Aparecido Boschero Raphael
Thomaz Soccol Vanete
Original Assignee
Imunova Analises Biologicas Ltda
Univ Federal Parana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imunova Analises Biologicas Ltda, Univ Federal Parana filed Critical Imunova Analises Biologicas Ltda
Priority to BR102020024403-5A priority Critical patent/BR102020024403B1/pt
Priority claimed from BR102020024403-5A external-priority patent/BR102020024403B1/pt
Publication of BR102020024403A2 publication Critical patent/BR102020024403A2/pt
Publication of BR102020024403A8 publication Critical patent/BR102020024403A8/pt
Publication of BR102020024403B1 publication Critical patent/BR102020024403B1/pt

Links

Abstract

antígeno peptídeo sintético p.sc2.s.309 aplicado em kit e método elisa para diagnóstico sorológico de covid-19 antígeno peptídeo sintético p.sc2.s.309 aplicado em kit e método elisa para diagnóstico sorológico de covid-19. frente ao panorama da pandemia de covid-19 há a necessidade de alternativas de diagnóstico. a presente invenção descreve um kit e método diagnóstico sorológico para covid-19. esta utiliza como antígeno o peptídeo sintético p.sc2.s.309 em imunoensaios no formato de teste elisa para identificar imunoglobulina igm em amostras biológicas de humanos, podendo também ser aplicada como teste de avidez. o peptídeo p.sc2.s.309 apresenta sequência artificial altamente similar ao do sars-cov-2 e de baixa similaridade com outros organismos próximos. este kit e seu método de uso apresentam alta sensibilidade (85%) e especificidade (100%) para detecção de igm. além de ser um teste de baixo custo e fácil execução, possibilitando um teste diagnóstico eficiente mais acessível.
BR102020024403-5A 2020-11-30 Antígenos peptídeos sintéticos para o diagnóstico do sars-cov-2 BR102020024403B1 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR102020024403-5A BR102020024403B1 (pt) 2020-11-30 Antígenos peptídeos sintéticos para o diagnóstico do sars-cov-2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR102020024403-5A BR102020024403B1 (pt) 2020-11-30 Antígenos peptídeos sintéticos para o diagnóstico do sars-cov-2

Publications (3)

Publication Number Publication Date
BR102020024403A2 true BR102020024403A2 (pt) 2022-05-10
BR102020024403A8 BR102020024403A8 (pt) 2022-08-09
BR102020024403B1 BR102020024403B1 (pt) 2023-08-22

Family

ID=

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116790249A (zh) * 2023-06-07 2023-09-22 湖北第二师范学院 一种紫外a波段碳点及其制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116790249A (zh) * 2023-06-07 2023-09-22 湖北第二师范学院 一种紫外a波段碳点及其制备方法

Also Published As

Publication number Publication date
BR102020024403A8 (pt) 2022-08-09

Similar Documents

Publication Publication Date Title
Elshemey et al. Evaluation of a rapid immunochromatographic test for detection of Brucella abortus antibodies in Egyptian cattle sera and milk.
Samartino et al. Validation of enzyme-linked immunosorbent assays for the diagnosis of bovine brucellosis
Rhodes et al. Comparative study of IFNγ and antibody tests for feline tuberculosis
JP2020516603A5 (pt)
ES512498A0 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
Day Introduction to antigen and antibody assays
Julián et al. An ELISA for five glycolipids from the cell wall of Mycobacterium tuberculosis:: Tween 20 interference in the assay
Al Jindan et al. Clinical Interpretation of Detection of IgM Anti-Antibody in the Absence of IgG and; a Diagnostic Challenge for Clinicians
Kumar et al. Development of the Com1 synthetic peptide-based Latex Agglutination Test (LAT) and its comparative evaluation with commercial indirect-ELISA for sero-screening of coxiellosis in cattle
Pilmis et al. Evolution of anti-SARS-CoV-2 immune response in a cohort of French healthcare workers followed for 7 months
US20210072235A1 (en) Method for diagnosing tuberculosis
Cooper et al. ELISA and immuno–polymerase chain reaction assays for the sensitive detection of melioidosis
BR9507389A (pt) Método para detectar a presença de uma espécie mycobacterium e um kit e anticorpos para uso no mesmo
BR102020024403A2 (pt) Antígenos peptídeos sintéticos para o diagnóstico do sars-cov-2
BR0011449A (pt) Método para detectar sìfilis usando antìgenos sintéticos
BR102020024378A2 (pt) Antígeno peptídeo sintético p.sc2.s.309 aplicado em kit e método elisa para diagnóstico sorológico de covid-19
Turner et al. Serological speciation of human schistosome infections by ELISA with a panel of three antigens
ATE282830T1 (de) Immuntest für human chromogranine a (cga), antikörper, reagenz und dazu geeigneter testsatz
Boggian et al. Infrequent detection of lipoarabinomannan antibodies in human immunodeficiency virus-associated mycobacterial disease. Swiss HIV Cohort Study
Minas et al. Validation of a competitive ELISA for diagnosis of Brucella melitensis infection in sheep and goats
Mythili et al. Development and comparative evaluation of a competitive ELISA with rose bengal test and a commercial indirect ELISA for serological diagnosis of brucellosis
Redhuan et al. Salivary anti-50 kDa antibodies as a useful biomarker for diagnosis of typhoid fever
Andrae et al. Antigen detection in canine blastomycosis: comparison of different antibody-antigen combinations in two competitive ELISAs
Shaheen et al. Evaluation of the response of human humoral antibodies to Salmonella typhi lipopolysaccharide in an area of endemic typhoid fever
Brown et al. Experimental syphilis in the chimpanzee. Immunoglobulin class of early antibodies reactive with Treponema pallidum.

Legal Events

Date Code Title Description
B03B Publication of an application: publication anticipated [chapter 3.2 patent gazette]
B03H Publication of an application: rectification [chapter 3.8 patent gazette]

Free format text: REFERENTE AO CODIGO 3.1 PUBLICADO NA RPI2679 DE 28/06/2022 RELATIVO AO CAMPO INID (57) TITULO. CONSIDEREM-SE OS DADOS ATUAIS

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/11/2020, OBSERVADAS AS CONDICOES LEGAIS

B22L Other matters related to patents and certificates of addition of invention: notification of licence offer (art 64 par 1 of lpi)

Free format text: CONDICOES CONTRATUAIS: 1) ROYALTIES: 5% (CINCO POR CENTO) DO PRECO DE VENDA, LIVRE DE IMPOSTOS; 2) PRAZO: ATE O TERMINO DE VIGENCIA DA PATENTE, EM 30/11/2040; 3) CONDICOES DE PAGAMENTO: ANUAL EM FUNCAO DAS VENDAS APURADAS NO PERIODO; 4) DISPONIBILIDADE DE "KNOW-HOW": SIM; 5) ASSISTENCIA TECNICA: NAO. --- OBS: CONSULTA A CARTA PATENTE PODERA SER FEITA ATRAVES DO ENDERECO ELETRONICO WWW.INPI.GOV.BR - NO ACESSO RAPIDO = BUSCA DE PROCESSOS = FACA LOGIN COM SENHA OU TECLE CONTINUAR = PATENTE = DIGITE O NUMERO DO PROCESSO = PESQUISAR. PARA ACESSAR, CADASTRE-SE NO PORTAL DO INPI.

B22L Other matters related to patents and certificates of addition of invention: notification of licence offer (art 64 par 1 of lpi)

Free format text: CONDICOES CONTRATUAIS: 1) ROYALTIES: 5% (CINCO POR CENTO) DO PRECO DE VENDA, LIVRE DE IMPOSTOS; 2) PRAZO: ATE O TERMINO DE VIGENCIA DA PATENTE, EM 30/11/2040; 3) CONDICOES DE PAGAMENTO: ANUAL EM FUNCAO DAS VENDAS APURADAS NO PERIODO; 4) DISPONIBILIDADE DE KNOW-HOW: SIM; 5) ASSISTENCIA TECNICA: NAO. --- OBS: CONSULTA A CARTA PATENTE PODERA SER FEITA ATRAVES DO ENDERECO ELETRONICO WWW.INPI.GOV.BR - NO ACESSO RAPIDO = BUSCA DE PROCESSOS = FACA LOGIN COM SENHA OU TECLE CONTINUAR = PATENTE = DIGITE O NUMERO DO PROCESSO = PESQUISAR. PARA ACESSAR, CADASTRE-SE NO PORTAL DO INPI.